血管內(nèi)皮生長(zhǎng)因子C(VEGFC)活性蛋白
Active Vascular Endothelial Growth Factor C (VEGFC)
VEGF-C; Flt4-L; VRPL; Vascular Endothelial Growth Factor-Related Protein
- 編號(hào)UAPA145Rb62
- 物種Oryctolagus cuniculus (Rabbit,兔) 相同的名稱,不同的物種。
- 緩沖液成份PBS, pH7.4, containing 5% Trehalose.
- 性狀凍干粉
- 純度> 90%
- 等電點(diǎn)8.5
- 應(yīng)用Cell?culture;?Activity?Assays.
- 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價(jià)格 暫無報(bào)價(jià) 暫無報(bào)價(jià) 暫無報(bào)價(jià) 暫無報(bào)價(jià) 暫無報(bào)價(jià)
- 欲了解實(shí)際交易價(jià)格和更多情況,請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
活性實(shí)驗(yàn)

Vascular Endothelial Growth Factor C (VEGFC) is a key lymphangiogenic factor that primarily binds to VEGFR-3 (FLT4), promoting lymphatic endothelial cell proliferation, migration, and survival. It also activates VEGFR-2 (KDR) upon proteolytic processing, contributing to angiogenesis. VEGFC is essential for embryonic lymphatic development and adult lymphatic remodeling.Besides,Vascular Endothelial Growth Factor D (VEGFD) has been identified as an interactor of VEGFC, thus a functional binding ELISA assay was conducted to detect the interaction of recombinant rabbit VEGFC and recombinant bovine VEGFD . Briefly, biotin-linked VEGFC were diluted serially in PBS, with 0.01% BSA (pH 7.4). Duplicate samples of 100μl were then transferred to VEGFD-coated microtiter wells and incubated for 1h at 37℃. Wells were washed with PBST 3 times and incubation with Streptavidin-HRP for 30min, then wells were aspirated and washed 5 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37℃. Finally, add 50μl stop solution to the wells and read at 450nm immediately. The binding activity of recombinant rabbit VEGFC and recombinant bovine VEGFD was shown in Figure 1, the EC50?for this effect is 0.43ug/mL.
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過一個(gè)月,-80°C不超過12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。
贈(zèng)品
增值服務(wù)
相關(guān)產(chǎn)品
編號(hào) | 適用物種:Oryctolagus cuniculus (Rabbit,兔) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
URPA145Rb01 | 血管內(nèi)皮生長(zhǎng)因子C(VEGFC)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
UEPA145Rb61 | 血管內(nèi)皮生長(zhǎng)因子C(VEGFC)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
UEPA145Rb62 | 血管內(nèi)皮生長(zhǎng)因子C(VEGFC)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
UAPA145Rb61 | 血管內(nèi)皮生長(zhǎng)因子C(VEGFC)活性蛋白 | Cell?culture;?Activity?Assays. |
UAPA145Rb62 | 血管內(nèi)皮生長(zhǎng)因子C(VEGFC)活性蛋白 | Cell?culture;?Activity?Assays. |
UPAA145Rb01 | 血管內(nèi)皮生長(zhǎng)因子C(VEGFC)多克隆抗體 | WB; IHC; ICC; IP. |
UPAA145Rb51 | 血管內(nèi)皮生長(zhǎng)因子C(VEGFC)多克隆抗體 | WB; IHC; ICC; IP. |
USEA145Rb | 血管內(nèi)皮生長(zhǎng)因子C(VEGFC)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
ULMA145Rb | 血管內(nèi)皮生長(zhǎng)因子C(VEGFC)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
雜志 | 參考文獻(xiàn) |
Journal of Cellular Biochemistry | Alternatively activated RAW264. 7 macrophages enhance tumor lymphangiogenesis in mouse lung adenocarcinoma [PubMed: 19241443] |
genetics and molecular research | Expression of COX-2 and VEGF-C in cholangiocarcinomas at different clinical and pathological stages [PubMed: 26125824] |
Experimental and Therapeutic | Fenofibrate inhibits the expression of VEGFC and VEGFR-3 in retinal pigmental epithelial cells exposed to hypoxia [PubMed: 26622498] |
Am J Pathol | IL-10 Indirectly Regulates Corneal Lymphangiogenesis and Resolution of Inflammation via Macrophages [PubMed: 26608451] |
PLoS One. | Interleukin-6 Induces Vascular Endothelial Growth Factor-C Expression via Src-FAK-STAT3 Signaling in Lymphatic Endothelial Cells. [pubmed:27383632] |
Oncology?Letters | RNAi-mediated?gene?silencing?of?vascular?endothelial?growth?factor?C?suppresses?growth?andinduces?apoptosis?in?mouse?breast?cancer?in?vitro?and in?vivo. [pubmed:27895746] |
Angiogenesis | Characterization of isolated liver sinusoidal endothelial cells for liver bioengineering [Pubmed:29582235] |
Oncology Reports | Effects of diphyllin as a novel V-ATPase inhibitor on TE-1 and ECA-109 cells [Pubmed:29328465] |
LABORATORY INVESTIGATION | Dynamic signature of lymphangiogenesis during acute kidney injury and chronic kidney disease [Pubmed: 31019289] |
Cutaneous and Ocular Toxicology | Isotretinoin does not alter VEGF-A and VEGF-C levels: Do retinoids behave differently in dose-dependent and/or in vivo/in vitro conditions? [Pubmed: 32722957] |